CytoAgents Receives Funding to Accelerate COVID-19 Clinical Trials for Cytokine Storm Treatment from Richard King Mellon Foundation

  

$250,000 Investment Part of Rapid Response Pandemic Solutions Package

© 2020 by CytoAgents

  • LI-In-Bug